Non-invasive ventilation for preoxygenation during prehospital anaesthesia - a prospective observational study

院前麻醉期间无创通气用于预充氧——一项前瞻性观察研究

阅读:2

Abstract

BACKGROUND: Preoxygenation is used to prevent hypoxia during anaesthesia and intubation. In a prehospital setting, preoxygenation is usually performed using a non-rebreather mask or a bag-valve-mask. These methods are however not sufficient for some critically ill patients. Non-invasive ventilation (NIV) has been shown to be more effective than other methods for preoxygenation of these patients in a hospital setting. Despite this, the use of NIV for preoxygenation has not been reported in a prehospital setting. The purpose of this study is to describe the prehospital use of, and experience with, NIV as a preoxygenation technique in patients undergoing prehospital emergency anaesthesia (PHEA). METHODS: In this prospective observational study, we included 42 patients preoxygenated with NIV for PHEA by one Finnish helicopter emergency medical services unit. We gathered data on, among other things, patient characteristics, vital signs, success of preoxygenation, post-intubation complications and mortality. In addition, we conducted a semi-structured survey on experiences of the use of NIV for preoxygenation among the prehospital physicians in the study unit. Descriptive analyses were performed as well as calculating confidence intervals. RESULTS: During the study period from October 2022 to May 2023, a total of 115 PHEAs were performed and NIV preoxygenation was used in 42 (n = 42/115, 37%) of these. Preoxygenation using NIV was technically successful in 100% of cases (n = 42/42, 95% CI 92-100). The median (IQR) oxygen saturation at HEMS arrival was 98% (95-99) and preoxygenation with NIV achieved a median (IQR) oxygen saturation post-intubation of 99% (97-100). No complications of hypoxia were documented, and the rate of pneumonia and mortality did not exceed what was expected based on literature. In the survey, 40% (n = 4/10) of physicians reported using NIV routinely for all patients while 60% (n = 6/10) only used it for those considered susceptible to desaturation. CONCLUSIONS: This study demonstrates that NIV for preoxygenation has been implemented and is frequently used in prehospital settings in Finland, and that the intervention seems technically successful without clear adverse events.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。